Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 3, 2016, Pages 355-368.e2

  Majumder, Kaustav ^a   Gupta, Arjun ^b   Arora, Nivedita ^a   Singh, Preet Paul ^c   Singh, Siddharth ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiposity; Malignancy; Pancreas; Survival

Indexed keywords

ASIA; BODY MASS; CANCER MORTALITY; DIABETES MELLITUS; DOSE RESPONSE; HUMAN; META ANALYSIS; OBESITY; OBSERVATIONAL STUDY; PANCREAS CANCER; PREMORBID OBESITY; REVIEW; SURGICAL MORTALITY; SYSTEMATIC REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION; COMPLICATION; HEALTH; MORTALITY; PANCREAS TUMOR;

BODY MASS INDEX; GLOBAL HEALTH; HUMANS; OBESITY; PANCREATIC NEOPLASMS;

EID: 84958653870     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.09.036     Document Type: Review

References (43)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015, 65:5-29.
2. Aune D., Greenwood D.C., Chan D.S., et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012, 23:843-852.
3. Bao Y., Giovannucci E.L., Kraft P., et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst 2013, 105:95-103.
4. Wolpin B.M., Bao Y., Qian Z.R., et al. Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 2013, 105:1027-1035.
5. Grote V.A., Rohrmann S., Nieters A., et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 2011, 54:3037-3046.
6. Li N., Grivennikov S.I., Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011, 19:429-431.
7. Gukovsky I., Li N., Todoric J., et al. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology 2013, 144:1199-1209.
8. Parkin E., O'Reilly D.A., Sherlock D.J., et al. Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 2014, 15:434-451.
9. Chan D.S., Vieira A.R., Aune D., et al. Body mass index and survival in women with breast cancer: systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014, 25:1901-1914.
10. Zhang X., Zhou G., Sun B., et al. Impact of obesity upon prostate cancer-associated mortality: a meta-analysis of 17 cohort studies. Oncol Lett 2015, 9:1307-1312.
11. Castillo J.J., Reagan J.L., Ingham R.R., et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res 2012, 36:868-875.
12. Li D., Morris J.S., Liu J., et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009, 301:2553-2562.
13. Lin Y., Fu R., Grant E., et al. Association of body mass index and risk of death from pancreatic cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev 2013, 22:244-250.
14. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
15. Hayden J.A., van der Windt D.A., Cartwright J.L., et al. Assessing bias in studies of prognostic factors. Ann Intern Med 2013, 158:280-286.
16. Chene G., Thompson S.G. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996, 144:610-621.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
20. Sterne J.A., Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54:1046-1055.
21. McWilliams R.R., Matsumoto M.E., Burch P.A., et al. Obesity adversely affects survival in pancreatic cancer patients. Cancer 2010, 116:5054-5062.
22. Reeves G.K., Pirie K., Beral V., et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007, 335:1134.
23. Yuan C., Bao Y., Wu C., et al. Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol 2013, 31:4229-4234.
24. Olson S.H., Chou J.F., Ludwig E., et al. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 2010, 127:2412-2419.
25. Gong Z., Holly E.A., Bracci P.M. Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Cancer Causes Control 2012, 23:1929-1937.
26. Ansary-Moghaddam A., Huxley R., Barzi F., et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006, 15:2435-2440.
27. Bethea T.N., Kitahara C.M., Sonderman J., et al. A pooled analysis of body mass index and pancreatic cancer mortality in african americans. Cancer Epidemiol Biomarkers Prev 2014, 23:2119-2125.
28. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
29. Batty G.D., Kivimaki M., Morrison D., et al. Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 2009, 18:673-675.
30. Gapstur S.M., Gann P.H., Lowe W., et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000, 283:2552-2558.
31. Lee I.M., Sesso H.D., Oguma Y., et al. Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 2003, 88:679-683.
32. Arnold L.D., Patel A.V., Yan Y., et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?. Cancer Epidemiol Biomarkers Prev 2009, 18:2397-2405.
33. Nakamura K., Nagata C., Wada K., et al. Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in Japan. Jpn J Clin Oncol 2011, 41:225-231.
34. Stevens R.J., Roddam A.W., Spencer E.A., et al. Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 2009, 124:2400-2405.
35. Coughlin S.S., Calle E.E., Patel A.V., et al. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000, 11:915-923.
36. Lin Y., Ueda J., Yagyu K., et al. A prospective cohort study of shift work and the risk of death from pancreatic cancer in Japanese men. Cancer Causes Control 2013, 24:1357-1361.
37. Balentine C.J., Enriquez J., Fisher W., et al. Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 2010, 14:1832-1837.
38. Wang D., Zheng W., Wang S.M., et al. Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer 2012, 64:48-56.
39. van Kruijsdijk R.C., van der Wall E., Visseren F.L. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009, 18:2569-2578.
40. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
41. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
42. Bullo M., Garcia-Lorda P., Megias I., et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003, 11:525-531.
43. Griggs J.J., Mangu P.B., Anderson H., et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012, 30:1553-1561.